Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
ソース:
Nasdaq GlobeNewswire
/
28 11 2023 05:59:00 America/Chicago
N/A
シェアする